Here are four insights:
1. The more than 8 million shares of common stock were priced at $15 per share to the public.
2. All offered by SI-Bone, the shares began trading on the NASDAQ global market Oct. 17.
3. In celebration of the shares going public, SI-Bone CEO and President Jeffrey Dunn rang the opening bell at the New York City-based NASDAQ MarketSite in Times Square Nov. 30.
4. SI-Bone created the iFuse Implant System, which is a minimally invasive surgical system designed to fuse the sacroiliac joint to treat sacroiliac joint dysfunction.
More articles on devices and implants:
Medtronic CEO Omar Ishrak visits Israel among recent, potential new acquisitions: 5 things to know
Exparel launches patient education website with non-opioid pain management information, resources
Former Zimmer Biomet SVP loses bid for severance in court: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
